Annual Revenue
$2.33 B
+$391.20 M+20.20%
31 December 2023
Summary:
United Therapeutics annual revenue is currently $2.33 billion, with the most recent change of +$391.20 million (+20.20%) on 31 December 2023. During the last 3 years, it has risen by +$844.20 million (+56.91%). UTHR annual revenue is now at all-time high.UTHR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$748.90 M
+$34.00 M+4.76%
30 September 2024
Summary:
United Therapeutics quarterly revenue is currently $748.90 million, with the most recent change of +$34.00 million (+4.76%) on 30 September 2024. Over the past year, it has increased by +$139.50 million (+22.89%). UTHR quarterly revenue is now at all-time high.UTHR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$2.76 B
+$139.50 M+5.33%
30 September 2024
Summary:
United Therapeutics TTM revenue is currently $2.76 billion, with the most recent change of +$139.50 million (+5.33%) on 30 September 2024. Over the past year, it has increased by +$551.90 million (+25.04%). UTHR TTM revenue is now at all-time high.UTHR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.2% | +22.9% | +25.0% |
| 3 y3 years | +56.9% | +68.4% | +66.5% |
| 5 y5 years | +43.0% | +86.5% | +81.4% |
UTHR Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +56.9% | at high | +80.4% | at high | +66.5% |
| 5 y | 5 years | at high | +60.6% | at high | +140.7% | at high | +95.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
United Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $748.90 M(+4.8%) | $2.76 B(+5.3%) |
| June 2024 | - | $714.90 M(+5.5%) | $2.62 B(+4.7%) |
| Mar 2024 | - | $677.70 M(+10.2%) | $2.50 B(+7.3%) |
| Dec 2023 | $2.33 B(+20.2%) | $614.70 M(+0.9%) | $2.33 B(+5.6%) |
| Sept 2023 | - | $609.40 M(+2.2%) | $2.20 B(+4.4%) |
| June 2023 | - | $596.50 M(+17.7%) | $2.11 B(+6.5%) |
| Mar 2023 | - | $506.90 M(+3.1%) | $1.98 B(+2.3%) |
| Dec 2022 | $1.94 B(+14.9%) | $491.50 M(-4.7%) | $1.94 B(+4.1%) |
| Sept 2022 | - | $516.00 M(+10.5%) | $1.86 B(+4.0%) |
| June 2022 | - | $466.90 M(+1.1%) | $1.79 B(+1.2%) |
| Mar 2022 | - | $461.90 M(+11.2%) | $1.77 B(+4.9%) |
| Dec 2021 | $1.69 B(+13.6%) | $415.20 M(-6.6%) | $1.69 B(+1.8%) |
| Sept 2021 | - | $444.70 M(-0.4%) | $1.66 B(+4.1%) |
| June 2021 | - | $446.50 M(+17.8%) | $1.59 B(+5.6%) |
| Mar 2021 | - | $379.10 M(-1.5%) | $1.51 B(+1.5%) |
| Dec 2020 | $1.48 B(+2.4%) | $384.90 M(+1.3%) | $1.48 B(+5.2%) |
| Sept 2020 | - | $380.10 M(+5.0%) | $1.41 B(-1.5%) |
| June 2020 | - | $362.00 M(+1.6%) | $1.43 B(-0.8%) |
| Mar 2020 | - | $356.30 M(+14.5%) | $1.44 B(-0.4%) |
| Dec 2019 | $1.45 B(-11.0%) | $311.10 M(-22.5%) | $1.45 B(-4.6%) |
| Sept 2019 | - | $401.50 M(+7.5%) | $1.52 B(-0.7%) |
| June 2019 | - | $373.60 M(+3.0%) | $1.53 B(-4.4%) |
| Mar 2019 | - | $362.60 M(-4.9%) | $1.60 B(-1.6%) |
| Dec 2018 | $1.63 B(-5.7%) | $381.40 M(-7.6%) | $1.63 B(-4.9%) |
| Sept 2018 | - | $412.70 M(-7.2%) | $1.71 B(-1.9%) |
| June 2018 | - | $444.50 M(+14.2%) | $1.74 B(-0.0%) |
| Mar 2018 | - | $389.20 M(-16.2%) | $1.74 B(+1.1%) |
| Dec 2017 | $1.73 B(+7.9%) | $464.70 M(+4.3%) | $1.73 B(+3.3%) |
| Sept 2017 | - | $445.50 M(+0.2%) | $1.67 B(+2.3%) |
| June 2017 | - | $444.60 M(+20.0%) | $1.63 B(+2.0%) |
| Mar 2017 | - | $370.50 M(-9.4%) | $1.60 B(+0.1%) |
| Dec 2016 | $1.60 B(+9.1%) | $409.00 M(+0.2%) | $1.60 B(+0.3%) |
| Sept 2016 | - | $408.20 M(-1.1%) | $1.59 B(+1.4%) |
| June 2016 | - | $412.60 M(+11.8%) | $1.57 B(+4.3%) |
| Mar 2016 | - | $369.00 M(-8.9%) | $1.51 B(+2.8%) |
| Dec 2015 | $1.47 B(+13.8%) | $404.90 M(+4.8%) | $1.47 B(+4.2%) |
| Sept 2015 | - | $386.20 M(+11.2%) | $1.41 B(+4.2%) |
| June 2015 | - | $347.20 M(+6.0%) | $1.35 B(+1.8%) |
| Mar 2015 | - | $327.50 M(-5.4%) | $1.33 B(+3.0%) |
| Dec 2014 | $1.29 B(+15.4%) | $346.34 M(+5.0%) | $1.29 B(+4.7%) |
| Sept 2014 | - | $329.95 M(+2.2%) | $1.23 B(+2.3%) |
| June 2014 | - | $322.80 M(+11.5%) | $1.20 B(+3.6%) |
| Mar 2014 | - | $289.40 M(+0.1%) | $1.16 B(+4.0%) |
| Dec 2013 | $1.12 B(+21.9%) | $289.02 M(-4.4%) | $1.12 B(+4.2%) |
| Sept 2013 | - | $302.23 M(+7.7%) | $1.07 B(+5.9%) |
| June 2013 | - | $280.61 M(+14.5%) | $1.01 B(+5.8%) |
| Mar 2013 | - | $245.14 M(+0.5%) | $957.00 M(+4.5%) |
| Dec 2012 | $916.08 M(+23.3%) | $243.82 M(+0.6%) | $916.08 M(+5.6%) |
| Sept 2012 | - | $242.47 M(+7.5%) | $867.44 M(+4.9%) |
| June 2012 | - | $225.58 M(+10.5%) | $826.71 M(+5.3%) |
| Mar 2012 | - | $204.21 M(+4.6%) | $784.88 M(+5.6%) |
| Dec 2011 | $743.18 M | $195.18 M(-3.3%) | $743.18 M(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $201.74 M(+9.8%) | $711.70 M(+4.9%) |
| June 2011 | - | $183.75 M(+13.1%) | $678.53 M(+7.8%) |
| Mar 2011 | - | $162.51 M(-0.7%) | $629.50 M(+5.6%) |
| Dec 2010 | $592.90 M(+60.3%) | $163.69 M(-2.9%) | $595.87 M(+10.1%) |
| Sept 2010 | - | $168.57 M(+25.1%) | $541.10 M(+15.2%) |
| June 2010 | - | $134.72 M(+4.5%) | $469.74 M(+12.1%) |
| Mar 2010 | - | $128.88 M(+18.3%) | $419.00 M(+13.3%) |
| Dec 2009 | $369.85 M(+31.4%) | $108.92 M(+12.0%) | $369.85 M(+9.8%) |
| Sept 2009 | - | $97.22 M(+15.8%) | $336.79 M(+7.1%) |
| June 2009 | - | $83.98 M(+5.3%) | $314.60 M(+5.2%) |
| Mar 2009 | - | $79.73 M(+5.1%) | $299.18 M(+6.3%) |
| Dec 2008 | $281.50 M(+33.4%) | $75.86 M(+1.1%) | $281.50 M(+6.0%) |
| Sept 2008 | - | $75.03 M(+9.4%) | $265.53 M(+6.4%) |
| June 2008 | - | $68.56 M(+10.5%) | $249.55 M(+7.2%) |
| Mar 2008 | - | $62.05 M(+3.6%) | $232.82 M(+10.4%) |
| Dec 2007 | $210.94 M(+32.1%) | $59.90 M(+1.4%) | $210.94 M(+7.1%) |
| Sept 2007 | - | $59.05 M(+13.9%) | $196.87 M(+10.5%) |
| June 2007 | - | $51.83 M(+29.0%) | $178.22 M(+7.0%) |
| Mar 2007 | - | $40.17 M(-12.3%) | $166.64 M(+4.4%) |
| Dec 2006 | $159.63 M(+37.7%) | $45.83 M(+13.4%) | $159.63 M(+11.3%) |
| Sept 2006 | - | $40.40 M(+0.4%) | $143.45 M(+5.4%) |
| June 2006 | - | $40.24 M(+21.4%) | $136.06 M(+8.1%) |
| Mar 2006 | - | $33.16 M(+11.9%) | $125.87 M(+8.6%) |
| Dec 2005 | $115.92 M(+57.5%) | $29.64 M(-10.2%) | $115.92 M(+7.4%) |
| Sept 2005 | - | $33.01 M(+9.8%) | $107.89 M(+13.7%) |
| June 2005 | - | $30.06 M(+29.5%) | $94.87 M(+14.1%) |
| Mar 2005 | - | $23.21 M(+7.4%) | $83.11 M(+12.9%) |
| Dec 2004 | $73.59 M(+38.0%) | $21.61 M(+8.1%) | $73.59 M(+12.2%) |
| Sept 2004 | - | $20.00 M(+9.3%) | $65.57 M(+8.2%) |
| June 2004 | - | $18.30 M(+33.7%) | $60.61 M(+7.7%) |
| Mar 2004 | - | $13.68 M(+0.7%) | $56.28 M(+5.5%) |
| Dec 2003 | $53.34 M(+77.1%) | $13.59 M(-9.6%) | $53.34 M(+3.0%) |
| Sept 2003 | - | $15.04 M(+7.6%) | $51.77 M(+23.7%) |
| June 2003 | - | $13.98 M(+30.2%) | $41.87 M(+6.1%) |
| Mar 2003 | - | $10.74 M(-10.7%) | $39.45 M(+31.0%) |
| Dec 2002 | $30.12 M(+425.5%) | $12.02 M(+134.4%) | $30.12 M(+52.8%) |
| Sept 2002 | - | $5.13 M(-55.7%) | $19.72 M(+24.0%) |
| June 2002 | - | $11.56 M(+722.5%) | $15.91 M(+181.2%) |
| Mar 2002 | - | $1.41 M(-13.2%) | $5.66 M(-1.3%) |
| Dec 2001 | $5.73 M(+179.7%) | $1.62 M(+23.1%) | $5.73 M(+16.9%) |
| Sept 2001 | - | $1.32 M(+0.1%) | $4.90 M(+22.9%) |
| June 2001 | - | $1.31 M(-11.4%) | $3.99 M(+23.8%) |
| Mar 2001 | - | $1.48 M(+87.7%) | $3.22 M(+57.2%) |
| Dec 2000 | $2.05 M(+369.5%) | $789.70 K(+95.5%) | $2.05 M(+37.0%) |
| Sept 2000 | - | $403.90 K(-26.1%) | $1.50 M(+25.5%) |
| June 2000 | - | $546.30 K(+76.6%) | $1.19 M(+59.8%) |
| Mar 2000 | - | $309.40 K(+30.8%) | $745.90 K(+39.0%) |
| Dec 1999 | $436.50 K(+711.3%) | $236.50 K(+136.5%) | $536.50 K(+78.8%) |
| Sept 1999 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| June 1999 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1999 | - | $100.00 K | $100.00 K |
| Dec 1998 | $53.80 K | - | - |
FAQ
- What is United Therapeutics annual revenue?
- What is the all time high annual revenue for United Therapeutics?
- What is United Therapeutics annual revenue year-on-year change?
- What is United Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for United Therapeutics?
- What is United Therapeutics quarterly revenue year-on-year change?
- What is United Therapeutics TTM revenue?
- What is the all time high TTM revenue for United Therapeutics?
- What is United Therapeutics TTM revenue year-on-year change?
What is United Therapeutics annual revenue?
The current annual revenue of UTHR is $2.33 B
What is the all time high annual revenue for United Therapeutics?
United Therapeutics all-time high annual revenue is $2.33 B
What is United Therapeutics annual revenue year-on-year change?
Over the past year, UTHR annual revenue has changed by +$391.20 M (+20.20%)
What is United Therapeutics quarterly revenue?
The current quarterly revenue of UTHR is $748.90 M
What is the all time high quarterly revenue for United Therapeutics?
United Therapeutics all-time high quarterly revenue is $748.90 M
What is United Therapeutics quarterly revenue year-on-year change?
Over the past year, UTHR quarterly revenue has changed by +$139.50 M (+22.89%)
What is United Therapeutics TTM revenue?
The current TTM revenue of UTHR is $2.76 B
What is the all time high TTM revenue for United Therapeutics?
United Therapeutics all-time high TTM revenue is $2.76 B
What is United Therapeutics TTM revenue year-on-year change?
Over the past year, UTHR TTM revenue has changed by +$551.90 M (+25.04%)